Skip to main content

Table 2 Weight and appendix parameters

From: Evaluation of Juniperus communis L. seed extract on benign prostatic hyperplasia induced in male Wistar rats

Groups Initial Body weight (g) Final body weight (g) Prostate weight (mg) % inhibition Prostate weight Prostate index × 10–3 % inhibition prostate index
Normal group (vehicle) 260 ± 8.99 300 ± 3.32 259 ± 4.05 0.866 ± 0.12
Disease group (IM TE injection) 248 ± 2.93* 219 ± 4.25*** 359 ± 5.91 *** 1.6419 ± 0.01***
Standard medicine group (TE + finasteride) 239 ± 4.96 260 ± 6.36### 293 ± 4.30### 66.5 1.1127### ± 0.01 68.2033
Group treated with 300 mg/kg JCS extract (TE + 300 mg/kg JCS) 237 ± 5.87# 273 ± 7.12### 320 ± 2.30### 39.4 1.1173### ± 0.01 67.6038
Group treated with 600 mg/kg JCS extract (TE + 600 mg/kg JCS) 267 ± 1.01# 280 ± 2.26### 299 ± 5.26### 60.3 1.1193### ± 0.02 67.3522
  1. Body weight, prostate weight and prostatic index in the examination groups were as follows: normal group (vehicle), disease group, standard medicine group, groups treated with 300 mg/kg and 600 mg/kg JCS extract for 28 days
  2. TE testosterone enanthate, JCS Juniperus communis
  3. The values are expressed as Mean ± SEM (N = 6 animals /group). ***p < 0.001, **p < 0.01, *p < 0.05 vs Control, ###p < 0.001, ##p < 0.01 and #p < 0.05 vs TE group
\